SG68049A1 - Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same - Google Patents

Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same

Info

Publication number: SG68049A1
Authority: SG; Singapore
Prior art keywords: pharmaceutical compositions; alkenoxy; taxanes; alkoxy; chain
Prior art date: 1993-03-22

Application number

SG9801036A

Other languages

English (en)

Inventor

Ki-Byung Chai

Robert A Holton

Hamd Idmoumaz

Hossain Nadizadeh

Yukio Suzuki

Chun Lin Tao

Kasthuri Rengan

Original Assignee

Univ Florida State

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-22

Filing date

1994-03-21

Publication date

2001-08-21

1994-03-21 Application filed by Univ Florida State filed Critical Univ Florida State

2001-08-21 Publication of SG68049A1 publication Critical patent/SG68049A1/en

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
229940123237 Taxane Drugs 0.000 title 1
125000003545 alkoxy group Chemical group 0.000 title 1
125000004104 aryloxy group Chemical group 0.000 title 1
239000002671 adjuvant Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
- C07C2603/62—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Hydrogenated Pyridines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Pyrrole Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)

SG9801036A 1993-03-22 1994-03-21 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same SG68049A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3485293A	1993-03-22	1993-03-22
US9471793A	1993-07-20	1993-07-20

Publications (1)

Publication Number	Publication Date
SG68049A1 true SG68049A1 (en)	2001-08-21

Family

ID=26711460

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG9801036A SG68049A1 (en)	1993-03-22	1994-03-21	Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
SG1996006328A SG73401A1 (en)	1993-03-22	1994-03-21	Taxanes having alkoxy alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing the same
SG9904638A SG89298A1 (en)	1993-03-22	1994-03-21	Novel taxanes having a furyl or thienyl substituted side-chain and pharmaceutical compositions containing them

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
SG1996006328A SG73401A1 (en)	1993-03-22	1994-03-21	Taxanes having alkoxy alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing the same
SG9904638A SG89298A1 (en)	1993-03-22	1994-03-21	Novel taxanes having a furyl or thienyl substituted side-chain and pharmaceutical compositions containing them

Country Status (12)

Country	Link
EP (6)	EP0690867B1 (fr)
JP (2)	JPH08508469A (fr)
AT (5)	ATE295363T1 (fr)
AU (3)	AU6367994A (fr)
CA (2)	CA2158862C (fr)
DE (5)	DE69434190T2 (fr)
DK (5)	DK0690867T3 (fr)
ES (5)	ES2241923T3 (fr)
IL (4)	IL109050A0 (fr)
PT (5)	PT1228759E (fr)
SG (3)	SG68049A1 (fr)
WO (2)	WO1994021250A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2712289B1 (fr) *	1993-11-08	1996-01-05	Rhone Poulenc Rorer Sa	Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) *	1994-06-28	1997-10-14	Tanabe Seiyaku Co., Ltd.	Baccatin derivatives and processes for preparing the same
US6500858B2 (en)	1994-10-28	2002-12-31	The Research Foundation Of The State University Of New York	Taxoid anti-tumor agents and pharmaceutical compositions thereof
EP0788493A1 (fr) *	1994-10-28	1997-08-13	The Research Foundation Of State University Of New York	Derives taxoides, leur preparation et leur utilisation en tant qu'agents antitumoraux
US6458976B1 (en)	1994-10-28	2002-10-01	The Research Foundation Of State University Of New York	Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
JP2964475B2 (ja)	1994-11-17	1999-10-18	田辺製薬株式会社	バッカチン誘導体及びその製法
CA2162759A1 (fr) *	1994-11-17	1996-05-18	Kenji Tsujihara	Derives de la baccatine et methodes de preparation
BR9608040B1 (pt)	1995-04-28	2010-02-23		composto taxàide pentacÍclico.
AU728057B2 (en) *	1995-09-13	2001-01-04	Florida State University	Radiosensitizing taxanes and their pharmaceutical preparations
FR2745814B1 (fr) *	1996-03-06	1998-04-03	Rhone Poulenc Rorer Sa	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2746797B1 (fr) *	1996-03-27	1998-06-19	Centre Nat Rech Scient	Nouveaux derives du 10-acetyldocetaxel et leur procede de preparation
AU724499B2 (en) *	1996-05-06	2000-09-21	Florida State University	1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
WO1998017656A1 (fr) *	1996-10-24	1998-04-30	Institute Armand-Frappier	Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers
WO2001057029A1 (fr) *	2000-02-02	2001-08-09	Florida State University Research Foundation, Inc.	Taxanes d'acetate c7-heterosubstituees utilisees en tant qu'agents antitumoraux
CO5280224A1 (es) *	2000-02-02	2003-05-30	Univ Florida State Res Found	Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
HUP0600302A2 (en) *	2000-02-02	2006-07-28	Univ Florida State Res Found	C10 ester substituted taxanes as antitumor agents
EP1785416A3 (fr)	2003-09-25	2007-05-30	Tapestry Pharmaceuticals, Inc.	Analogues de 9, 10-alpha, alpha-OH-Taxane et méthodes pour leur production
EP1810968A3 (fr) *	2003-09-25	2007-08-08	Tapestry Pharmaceuticals, Inc.	Analogues de taxane 9, 10-a, a-OH et leur procédé de production
EP1737444A4 (fr) *	2004-03-05	2008-05-21	Univ Florida State Res Found	Taxanes a substitution de c7 lactyloxy-
JP2008546646A (ja) *	2005-06-10	2008-12-25	フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド	β−ラクタムの鏡像異性体混合物の分離
US11786504B2 (en)	2006-09-28	2023-10-17	Tapestry Pharmaceuticals, Inc.	Taxane analogs for the treatment of brain cancer
WO2008121476A1 (fr)	2007-03-28	2008-10-09	Tapestry Pharmaceuticals, Inc.	Analogues de taxane biologiquement actifs, et procédés de traitement par administration orale
US11873308B2 (en)	2006-11-06	2024-01-16	Tapestry Pharmaceuticals, Inc.	Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (fr)	2007-02-28	2008-09-12	Tapestry Pharmaceuticals, Inc	Analogues de taxane pour le traitement du cancer du cerveau

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6075458A (ja) *	1983-06-17	1985-04-27	Osaka Soda Co Ltd	３，４−ジフエニル−１−（４−置換）アリ−ルメチルアゼチジン−２−オンの製法
EP0144840A2 (fr) *	1983-11-18	1985-06-19	Takeda Chemical Industries, Ltd.	Bêta-lactames optiquement actives et procédé pour leur préparation
US5006650A (en) *	1987-02-11	1991-04-09	The Upjohn Company	Novel N-1 substituted beta-lactams as antibiotics

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61243079A (ja) *	1985-04-01	1986-10-29	Mect Corp	１−（アルコキシカルボニルアルキル）−４−（２−フリル）−３−置換−２−アゼチジノン及びその製造方法
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4942184A (en) *	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
US5175315A (en) *	1989-05-31	1992-12-29	Florida State University	Method for preparation of taxol using β-lactam
AU637109B2 (en) *	1989-06-22	1993-05-20	Rijksuniversiteit Utrecht	Improved synthesis of beta-lactams using a metal compound
US5136060A (en) *	1989-11-14	1992-08-04	Florida State University	Method for preparation of taxol using an oxazinone
US5283253A (en) *	1991-09-23	1994-02-01	Florida State University	Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
DE69230379T2 (de) *	1991-09-23	2000-05-25	Bristol-Myers Squibb Co., New York	10-disacetoxytaxolderivate
ATE258171T1 (de) *	1991-09-23	2004-02-15	Univ Florida State	Metallalkoxide
US5250683A (en) *	1991-09-23	1993-10-05	Florida State University	Certain substituted taxanes and pharmaceutical compositions containing them
US5284865A (en) *	1991-09-23	1994-02-08	Holton Robert A	Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
US5229526A (en) *	1991-09-23	1993-07-20	Florida State University	Metal alkoxides
US5227400A (en) *	1991-09-23	1993-07-13	Florida State University	Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) *	1991-09-23	1993-09-07	Florida State University	Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
FR2688518B1 (fr) *	1992-03-13	1994-05-06	Rhone Poulenc Rorer Sa	Procede de preparation de derives du taxane.
CA2130578A1 (fr) *	1992-04-17	1993-10-28	Geewananda P. Gunawardana	Derives de taxol
FR2696460B1 (fr) *	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.

1994
- 1994-03-21 DK DK94911675T patent/DK0690867T3/da active
- 1994-03-21 DE DE69434190T patent/DE69434190T2/de not_active Expired - Fee Related
- 1994-03-21 IL IL10905094A patent/IL109050A0/xx unknown
- 1994-03-21 JP JP6521307A patent/JPH08508469A/ja active Pending
- 1994-03-21 JP JP6521330A patent/JPH08508255A/ja active Pending
- 1994-03-21 SG SG9801036A patent/SG68049A1/en unknown
- 1994-03-21 WO PCT/US1994/003053 patent/WO1994021250A1/fr not_active Ceased
- 1994-03-21 SG SG1996006328A patent/SG73401A1/en unknown
- 1994-03-21 PT PT02009839T patent/PT1228759E/pt unknown
- 1994-03-21 SG SG9904638A patent/SG89298A1/en unknown
- 1994-03-21 EP EP94911675A patent/EP0690867B1/fr not_active Expired - Lifetime
- 1994-03-21 EP EP02009839A patent/EP1228759B1/fr not_active Expired - Lifetime
- 1994-03-21 AT AT02009840T patent/ATE295363T1/de not_active IP Right Cessation
- 1994-03-21 ES ES02009840T patent/ES2241923T3/es not_active Expired - Lifetime
- 1994-03-21 PT PT02009840T patent/PT1227093E/pt unknown
- 1994-03-21 DK DK02019282T patent/DK1260223T3/da active
- 1994-03-21 AU AU63679/94A patent/AU6367994A/en not_active Abandoned
- 1994-03-21 EP EP02019282A patent/EP1260223B1/fr not_active Expired - Lifetime
- 1994-03-21 IL IL180090A patent/IL180090A0/en unknown
- 1994-03-21 DK DK02009839T patent/DK1228759T3/da active
- 1994-03-21 PT PT02019282T patent/PT1260223E/pt unknown
- 1994-03-21 DK DK02009840T patent/DK1227093T3/da active
- 1994-03-21 ES ES94910982T patent/ES2211879T3/es not_active Expired - Lifetime
- 1994-03-21 ES ES94911675T patent/ES2193155T3/es not_active Expired - Lifetime
- 1994-03-21 AT AT02009839T patent/ATE284689T1/de not_active IP Right Cessation
- 1994-03-21 AT AT02019282T patent/ATE295164T1/de not_active IP Right Cessation
- 1994-03-21 PT PT94910982T patent/PT689436E/pt unknown
- 1994-03-21 WO PCT/US1994/003097 patent/WO1994021651A1/fr not_active Ceased
- 1994-03-21 EP EP02009840A patent/EP1227093B1/fr not_active Expired - Lifetime
- 1994-03-21 IL IL109052A patent/IL109052A/en not_active IP Right Cessation
- 1994-03-21 DE DE69434373T patent/DE69434373T2/de not_active Expired - Fee Related
- 1994-03-21 ES ES02019282T patent/ES2242807T3/es not_active Expired - Lifetime
- 1994-03-21 DE DE69434374T patent/DE69434374T2/de not_active Expired - Fee Related
- 1994-03-21 DE DE69433355T patent/DE69433355T2/de not_active Expired - Fee Related
- 1994-03-21 PT PT94911675T patent/PT690867E/pt unknown
- 1994-03-21 EP EP03027078A patent/EP1398028A3/fr not_active Withdrawn
- 1994-03-21 CA CA002158862A patent/CA2158862C/fr not_active Expired - Fee Related
- 1994-03-21 CA CA002158454A patent/CA2158454C/fr not_active Expired - Fee Related
- 1994-03-21 AT AT94910982T patent/ATE254914T1/de not_active IP Right Cessation
- 1994-03-21 AT AT94911675T patent/ATE232871T1/de not_active IP Right Cessation
- 1994-03-21 DE DE69432141T patent/DE69432141T2/de not_active Expired - Fee Related
- 1994-03-21 ES ES02009839T patent/ES2232694T3/es not_active Expired - Lifetime
- 1994-03-21 AU AU64138/94A patent/AU691804B2/en not_active Ceased
- 1994-03-21 DK DK94910982T patent/DK0689436T3/da active
- 1994-03-21 EP EP94910982A patent/EP0689436B1/fr not_active Expired - Lifetime
1998
- 1998-08-03 AU AU78636/98A patent/AU714180B2/en not_active Ceased
2008
- 2008-04-17 IL IL190945A patent/IL190945A0/en unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6075458A (ja) *	1983-06-17	1985-04-27	Osaka Soda Co Ltd	３，４−ジフエニル−１−（４−置換）アリ−ルメチルアゼチジン−２−オンの製法
EP0144840A2 (fr) *	1983-11-18	1985-06-19	Takeda Chemical Industries, Ltd.	Bêta-lactames optiquement actives et procédé pour leur préparation
US5006650A (en) *	1987-02-11	1991-04-09	The Upjohn Company	Novel N-1 substituted beta-lactams as antibiotics

Also Published As

Publication number	Publication date
IL190945A0 (en)	2009-02-11
JPH08508255A (ja)	1996-09-03
WO1994021250A1 (fr)	1994-09-29
ATE295363T1 (de)	2005-05-15
SG89298A1 (en)	2002-06-18
AU714180B2 (en)	1999-12-23
DE69432141T2 (de)	2003-07-31
DE69434373T2 (de)	2006-03-09
DK0690867T3 (da)	2003-06-10
EP1260223A1 (fr)	2002-11-27
DE69434373D1 (de)	2005-06-16
DE69434374D1 (de)	2005-06-16
DE69434190D1 (de)	2005-01-20
EP1227093A2 (fr)	2002-07-31
IL109052A (en)	2009-07-20
EP0689436A1 (fr)	1996-01-03
EP1227093A3 (fr)	2002-08-07
CA2158862C (fr)	2006-10-10
ATE254914T1 (de)	2003-12-15
ES2242807T3 (es)	2005-11-16
ATE284689T1 (de)	2005-01-15
EP0689436A4 (fr)	1996-02-07
PT1228759E (pt)	2005-04-29
AU6367994A (en)	1994-10-11
CA2158862A1 (fr)	1994-09-29
ATE295164T1 (de)	2005-05-15
DE69434190T2 (de)	2005-05-25
CA2158454A1 (fr)	1994-09-29
DK0689436T3 (da)	2004-03-29
EP1228759B1 (fr)	2004-12-15
EP1228759A2 (fr)	2002-08-07
EP1398028A2 (fr)	2004-03-17
AU6413894A (en)	1994-10-11
CA2158454C (fr)	2006-05-23
EP0690867A4 (fr)	1996-03-20
ATE232871T1 (de)	2003-03-15
EP1260223B1 (fr)	2005-05-11
ES2211879T3 (es)	2004-07-16
DE69433355D1 (de)	2004-01-08
DK1227093T3 (da)	2005-08-29
EP0690867A1 (fr)	1996-01-10
PT1260223E (pt)	2005-09-30
PT690867E (pt)	2003-06-30
EP0690867B1 (fr)	2003-02-19
JPH08508469A (ja)	1996-09-10
EP0689436B1 (fr)	2003-11-26
PT689436E (pt)	2004-04-30
EP1398028A3 (fr)	2004-03-24
WO1994021651A1 (fr)	1994-09-29
PT1227093E (pt)	2005-09-30
ES2241923T3 (es)	2005-11-01
DK1260223T3 (da)	2005-09-05
AU7863698A (en)	1998-10-01
EP1228759A3 (fr)	2002-09-25
AU691804B2 (en)	1998-05-28
DE69433355T2 (de)	2004-05-27
DE69434374T2 (de)	2005-11-24
IL180090A0 (en)	2007-05-15
DE69432141D1 (de)	2003-03-27
IL109052A0 (en)	1994-06-24
SG73401A1 (en)	2000-06-20
DK1228759T3 (da)	2005-04-18
ES2232694T3 (es)	2005-06-01
EP1227093B1 (fr)	2005-05-11
ES2193155T3 (es)	2003-11-01
IL109050A0 (en)	1994-06-24

Publication	Publication Date	Title
SG68049A1 (en)	2001-08-21	Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
PT951474E (pt)	2002-11-29	Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
AU2001289820A1 (en)	2002-03-04	Novel pharmaceutical composition for administering n-0923
UY24386A1 (es)	2001-08-27	Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
ES2126919T3 (es)	1999-04-01	Taxanos semisinteticos con actividad antitumoral.
TW347389B (en)	1998-12-11	Taxoids, their preparation and pharmaceutical compositions containing them
DE60206940D1 (de)	2005-12-01	Pektin und ascorbinsäure enthaltende zusammensetzungen
DE60217315D1 (de)	2007-02-15	Pharmazeutische zusammensetzungen von rapamycines
ATE401325T1 (de)	2008-08-15	C10-carbamoyloxysubstituierte taxane als antitumormittel
IL109049A0 (en)	1994-06-24	Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
ZA941862B (en)	1994-10-17	Novel taxanes having a furyl or thienyl substituted side-chain and pharmaceutical compositions containing them.
MXPA04006675A (es)	2004-10-04	Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.